Matches in Nanopublications for { ?s ?p "[In comparison with genetically undefined patients, LRRK2 mutation carriers had more severe motor symptoms (median Unified Parkinson's Disease Rating Scale scores approximately 1.6 times higher, p<0.001), a higher rate of dyskinesia (OR 4.21, p=0.002) and use of dopamine agonists (OR 3.64, p<0.001), and less postural tremor (OR 0.21, p<0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP866972.RAtSBJWqhY19_cQBuxWjnM2ju-7BwY4mYRtjJjUuIBwZU130_assertion description "[In comparison with genetically undefined patients, LRRK2 mutation carriers had more severe motor symptoms (median Unified Parkinson's Disease Rating Scale scores approximately 1.6 times higher, p<0.001), a higher rate of dyskinesia (OR 4.21, p=0.002) and use of dopamine agonists (OR 3.64, p<0.001), and less postural tremor (OR 0.21, p<0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866972.RAtSBJWqhY19_cQBuxWjnM2ju-7BwY4mYRtjJjUuIBwZU130_provenance.
- NP429705.RAonoHvYtHczQ6Mzp7JtIZnLqGLT1WcucUKwr8M2vm03o130_assertion description "[In comparison with genetically undefined patients, LRRK2 mutation carriers had more severe motor symptoms (median Unified Parkinson's Disease Rating Scale scores approximately 1.6 times higher, p<0.001), a higher rate of dyskinesia (OR 4.21, p=0.002) and use of dopamine agonists (OR 3.64, p<0.001), and less postural tremor (OR 0.21, p<0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429705.RAonoHvYtHczQ6Mzp7JtIZnLqGLT1WcucUKwr8M2vm03o130_provenance.